Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG ...

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen's senior management team will host the call, which ...

Viridian Therapeutics received breakthrough therapy designation from the FDA for veligrotug for the treatment of thyroid eye ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

The final phase of Mumbai Metro Line 3 between Acharya Atre Chowk in Worli and Cuffe Parade in south Mumbai will become operational in August, Maharashtra Chief Minister Devendra Fadnavis announced on ...

Researchers have discovered a promising new drug combination that significantly lowers “bad” LDL cholesterol for people whose ...

Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation Reduction Act (IRA) was passed.

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Q2 2025 Management View CEO Mitchell Steiner emphasized Veru’s focus on its obesity program, highlighting the positive Phase 2b clinical trial results for enobosarm. This drug, when combined with ...

Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET. Company Participants. Stephanie Fagan - Chief Corporate Affairs Officer Rob Bar ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...